{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:19:52Z","timestamp":1780406392410,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012486","name":"Innovation-Driven Project of Central South University","doi-asserted-by":"publisher","award":["2023ZZTS0570"],"award-info":[{"award-number":["2023ZZTS0570"]}],"id":[{"id":"10.13039\/501100012486","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ30869"],"award-info":[{"award-number":["2023JJ30869"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JK2109"],"award-info":[{"award-number":["2024JK2109"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20384"],"award-info":[{"award-number":["U21A20384"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Project Program of the State Key Laboratory of Proteomics","award":["SKLP\u2010O201805"],"award-info":[{"award-number":["SKLP\u2010O201805"]}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["2024WZ9001"],"award-info":[{"award-number":["2024WZ9001"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Life Science Academy","award":["2024100CB0170"],"award-info":[{"award-number":["2024100CB0170"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03858-1","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T12:45:31Z","timestamp":1763815531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting CAD with a tumor microenvironment-responsive nano-heterojunction for synergistic induction of cuproptosis and inhibition of colorectal cancer progression"],"prefix":"10.1186","volume":"23","author":[{"given":"Yuanchu","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihang","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongpeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanni","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanxian","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"issue":"3","key":"3858_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3858_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233\u201354. https:\/\/doi.org\/10.3322\/caac.21772.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"3858_CR3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.6004\/jnccn.2024.0041","volume":"22","author":"AB Benson","year":"2024","unstructured":"Benson AB, Venook AP, Adam M, et al. NCCN guidelines\u00ae insights: rectal cancer, version 3.2024. J Natl Compr Canc Netw. 2024;22(6):366\u201375. https:\/\/doi.org\/10.6004\/jnccn.2024.0041.","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"3858_CR4","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386\u2013422. https:\/\/doi.org\/10.1093\/annonc\/mdw235.","journal-title":"Ann Oncol"},{"issue":"2","key":"3858_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1200\/JCO.21.01015","volume":"40","author":"HJ Lenz","year":"2022","unstructured":"Lenz HJ, Van Cutsem E, Luisa Limon M, et al. First-line Nivolumab plus low-dose Ipilimumab for microsatellite instability-high\/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study. J Clin Oncol. 2022;40(2):161\u201370. https:\/\/doi.org\/10.1200\/JCO.21.01015.","journal-title":"J Clin Oncol"},{"issue":"19","key":"3858_CR6","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1200\/JCO.22.02774","volume":"41","author":"C Tournigand","year":"2023","unstructured":"Tournigand C, Andr\u00e9 T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol. 2023;41(19):3469\u201377. https:\/\/doi.org\/10.1200\/JCO.22.02774.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3858_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.canlet.2016.08.022","volume":"382","author":"S Hu","year":"2016","unstructured":"Hu S, Dai H, Li T, et al. Broad RTK-targeted therapy overcomes molecular heterogeneity-driven resistance to cetuximab via vectored immunoprophylaxis in colorectal cancer. Cancer Lett. 2016;382(1):32\u201343. https:\/\/doi.org\/10.1016\/j.canlet.2016.08.022.","journal-title":"Cancer Lett"},{"key":"3858_CR8","doi-asserted-by":"publisher","unstructured":"Rm J, X Q, Cf L, et al. ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer. Nature communications. 2022;13(1). https:\/\/doi.org\/10.1038\/s41467-022-33172-5","DOI":"10.1038\/s41467-022-33172-5"},{"issue":"1","key":"3858_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41568-024-00763-x","volume":"25","author":"R Arafeh","year":"2025","unstructured":"Arafeh R, Shibue T, Dempster JM, Hahn WC, Vazquez F. The present and future of the cancer dependency map. Nat Rev Cancer. 2025;25(1):59\u201373. https:\/\/doi.org\/10.1038\/s41568-024-00763-x.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"3858_CR10","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1056\/NEJMc2209706","volume":"387","author":"MS Copur","year":"2022","unstructured":"Copur MS, Tun SM, Duckert R. PD-1 blockade in mismatch repair-deficient rectal cancer. N Engl J Med. 2022;387(9):854\u20135. https:\/\/doi.org\/10.1056\/NEJMc2209706.","journal-title":"N Engl J Med"},{"issue":"1","key":"3858_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12943-023-01713-1","volume":"22","author":"JR Fleischer","year":"2023","unstructured":"Fleischer JR, Schmitt AM, Haas G, et al. Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution. Mol Cancer. 2023;22(1):17. https:\/\/doi.org\/10.1186\/s12943-023-01713-1.","journal-title":"Mol Cancer"},{"issue":"1","key":"3858_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","volume":"8","author":"D Fan","year":"2023","unstructured":"Fan D, Cao Y, Cao M, Wang Y, Cao Y, Gong T. Nanomedicine in cancer therapy. Signal Transduct Target Ther. 2023;8(1):293. https:\/\/doi.org\/10.1038\/s41392-023-01536-y.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"3858_CR13","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1021\/acs.chemrev.0c00779","volume":"121","author":"M Izci","year":"2021","unstructured":"Izci M, Maksoudian C, Manshian BB, Soenen SJ. The use of alternative strategies for enhanced nanoparticle delivery to solid tumors. Chem Rev. 2021;121(3):1746\u2013803. https:\/\/doi.org\/10.1021\/acs.chemrev.0c00779.","journal-title":"Chem Rev"},{"issue":"21","key":"3858_CR14","doi-asserted-by":"publisher","first-page":"7579","DOI":"10.1039\/d2cs00998f","volume":"52","author":"L Fu","year":"2023","unstructured":"Fu L, Zhang Y, Farokhzad RA, Mendes BB, Conde J, Shi J. \u201cPassive\u201d nanoparticles for organ-selective systemic delivery: design, mechanism and perspective. Chem Soc Rev. 2023;52(21):7579\u2013601. https:\/\/doi.org\/10.1039\/d2cs00998f.","journal-title":"Chem Soc Rev"},{"issue":"2","key":"3858_CR15","doi-asserted-by":"publisher","first-page":"336","DOI":"10.20892\/j.issn.2095-3941.2020.0510","volume":"18","author":"Y Xue","year":"2021","unstructured":"Xue Y, Gao Y, Meng F, Luo L. Recent progress of nanotechnology-based theranostic systems in cancer treatments. Cancer Biol Med. 2021;18(2):336\u201351. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2020.0510.","journal-title":"Cancer Biol Med"},{"key":"3858_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jconrel.2021.01.022","volume":"331","author":"F Andrade","year":"2021","unstructured":"Andrade F, Rafael D, Vilar-Hern\u00e1ndez M, et al. Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo. J Control Release. 2021;331:198\u2013212. https:\/\/doi.org\/10.1016\/j.jconrel.2021.01.022.","journal-title":"J Control Release"},{"issue":"19","key":"3858_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914641","volume":"24","author":"T T\u00e9llez","year":"2023","unstructured":"T\u00e9llez T, Martin-Garc\u00eda D, Redondo M, Garc\u00eda-Aranda M. Clusterin expression in colorectal carcinomas. Int J Mol Sci. 2023;24(19):14641. https:\/\/doi.org\/10.3390\/ijms241914641.","journal-title":"Int J Mol Sci"},{"key":"3858_CR18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jconrel.2024.04.007","volume":"369","author":"Y Liu","year":"2024","unstructured":"Liu Y, Lin Y, Xiao H, et al. mRNA-responsive two-in-one nanodrug for enhanced anti-tumor chemo-gene therapy. J Control Release. 2024;369:765\u201374. https:\/\/doi.org\/10.1016\/j.jconrel.2024.04.007.","journal-title":"J Control Release"},{"issue":"1","key":"3858_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01909-z","volume":"21","author":"Y Dutt","year":"2023","unstructured":"Dutt Y, Pandey RP, Dutt M, et al. Therapeutic applications of nanobiotechnology. J Nanobiotechnol. 2023;21(1):148. https:\/\/doi.org\/10.1186\/s12951-023-01909-z.","journal-title":"J Nanobiotechnol"},{"issue":"15","key":"3858_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202205746","volume":"35","author":"J Yong","year":"2023","unstructured":"Yong J, Mellick AS, Whitelock J, Wang J, Liang K. A biomolecular toolbox for precision nanomotors. Adv Mater. 2023;35(15):e2205746. https:\/\/doi.org\/10.1002\/adma.202205746.","journal-title":"Adv Mater"},{"issue":"1","key":"3858_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13045-024-01631-9","volume":"17","author":"X Yang","year":"2024","unstructured":"Yang X, Wu H. RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms. J Hematol Oncol. 2024;17(1):108. https:\/\/doi.org\/10.1186\/s13045-024-01631-9.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"3858_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41573-020-0068-6","volume":"19","author":"AR Moore","year":"2020","unstructured":"Moore AR, Rosenberg SC, McCormick F, Malek S. RAS-targeted therapies: is the undruggable drugged? Nat Rev Drug Discov. 2020;19(8):533\u201352. https:\/\/doi.org\/10.1038\/s41573-020-0068-6.","journal-title":"Nat Rev Drug Discov"},{"key":"3858_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2025.108889","volume":"273","author":"N Hitchen","year":"2025","unstructured":"Hitchen N, Williams S, Desai J. Recent advances in therapeutic targeting of the KRAS pathway in cancer. Pharmacol Ther. 2025;273:108889. https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108889.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"3858_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189108","volume":"1879","author":"W Ye","year":"2024","unstructured":"Ye W, Lu X, Qiao Y, Ou WB. Activity and resistance to KRASG12C inhibitors in non-small cell lung cancer and colorectal cancer. Biochim Biophys Acta Rev Cancer. 2024;1879(3):189108. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189108.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"2","key":"3858_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2204619","volume":"387","author":"PA J\u00e4nne","year":"2022","unstructured":"J\u00e4nne PA, Riely GJ, Gadgeel SM, et al. Adagrasib in non\u2013small-cell lung cancer harboring a KRASG12C mutation. N Engl J Med. 2022;387(2):120\u201331. https:\/\/doi.org\/10.1056\/NEJMoa2204619.","journal-title":"N Engl J Med"},{"issue":"1","key":"3858_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00793-6","volume":"9","author":"K Maruyama","year":"2025","unstructured":"Maruyama K, Shimizu Y, Nomura Y, et al. Mechanisms of KRAS inhibitor resistance in KRAS-mutant colorectal cancer harboring Her2 amplification and aberrant KRAS localization. NPJ Precis Oncol. 2025;9(1):4. https:\/\/doi.org\/10.1038\/s41698-024-00793-6.","journal-title":"NPJ Precis Oncol"},{"issue":"3","key":"3858_CR27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41571-023-00852-0","volume":"21","author":"AJ Hanrahan","year":"2024","unstructured":"Hanrahan AJ, Chen Z, Rosen N, Solit DB. BRAF - a tumour-agnostic drug target with lineage-specific dependencies. Nat Rev Clin Oncol. 2024;21(3):224\u201347. https:\/\/doi.org\/10.1038\/s41571-023-00852-0.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"3858_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s43018-022-00508-5","volume":"4","author":"A Ruiz-Saenz","year":"2023","unstructured":"Ruiz-Saenz A, Atreya CE, Wang C, et al. A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAFV600E colorectal tumors. Nat Cancer. 2023;4(2):240\u201356. https:\/\/doi.org\/10.1038\/s43018-022-00508-5.","journal-title":"Nat Cancer"},{"issue":"1","key":"3858_CR29","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/s41467-024-45852-5","volume":"15","author":"Q Wan","year":"2024","unstructured":"Wan Q, Tavakoli L, Wang TY, et al. Hijacking of nucleotide biosynthesis and deamidation-mediated glycolysis by an oncogenic herpesvirus. Nat Commun. 2024;15(1):1442. https:\/\/doi.org\/10.1038\/s41467-024-45852-5.","journal-title":"Nat Commun"},{"issue":"1","key":"3858_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1053\/j.gastro.2021.08.052","volume":"162","author":"L Guo","year":"2022","unstructured":"Guo L, Yi X, Chen L, et al. Single-cell DNA sequencing reveals punctuated and gradual clonal evolution in hepatocellular carcinoma. Gastroenterology. 2022;162(1):238\u201352. https:\/\/doi.org\/10.1053\/j.gastro.2021.08.052.","journal-title":"Gastroenterology"},{"key":"3858_CR31","doi-asserted-by":"publisher","DOI":"10.34133\/research.0649","volume":"8","author":"X Xie","year":"2025","unstructured":"Xie X, Zhang B, Peng J, et al. EGF-upregulated lncRNA ESSENCE promotes colorectal cancer growth through stabilizing CAD and ferroptosis defense. Research. 2025;8:0649. https:\/\/doi.org\/10.34133\/research.0649.","journal-title":"Research"},{"issue":"3","key":"3858_CR32","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s13402-023-00899-2","volume":"47","author":"G Li","year":"2024","unstructured":"Li G, Xiao K, Li Y, Gao J, He S, Li T. CHIP promotes CAD ubiquitination and degradation to suppress the proliferation and colony formation of glioblastoma cells. Cell Oncol (Dordr). 2024;47(3):851\u201365. https:\/\/doi.org\/10.1007\/s13402-023-00899-2.","journal-title":"Cell Oncol (Dordr)"},{"key":"3858_CR33","doi-asserted-by":"publisher","unstructured":"Pan J, Zhang M, Rao D, et al. CAD manipulates tumor intrinsic DHO\/UBE4B\/NF-\u03baB pathway and fuels macrophage cross-talk, promoting HCC metastasis. Hepatology. Published online 2025 March 12 https:\/\/doi.org\/10.1097\/HEP.0000000000001304","DOI":"10.1097\/HEP.0000000000001304"},{"issue":"1","key":"3858_CR34","doi-asserted-by":"publisher","first-page":"5006","DOI":"10.1038\/s41467-025-60144-2","volume":"16","author":"J Ma","year":"2025","unstructured":"Ma J, Zhao J, Zhang C, et al. Cleavage of CAD by caspase-3 determines the cancer cell fate during chemotherapy. Nat Commun. 2025;16(1):5006. https:\/\/doi.org\/10.1038\/s41467-025-60144-2.","journal-title":"Nat Commun"},{"issue":"1","key":"3858_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12935-025-03743-9","volume":"25","author":"J Wen","year":"2025","unstructured":"Wen J, Wen K, Tao M, et al. Integrated analysis reveals an immune evasion prognostic signature for predicting the overall survival in patients with hepatocellular carcinoma. Cancer Cell Int. 2025;25(1):101. https:\/\/doi.org\/10.1186\/s12935-025-03743-9.","journal-title":"Cancer Cell Int"},{"issue":"10","key":"3858_CR36","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein JN, Collisson EA, Mills GB, et al. The Cancer Genome Atlas pan-cancer analysis project. Nat Genet. 2013;45(10):1113\u201320. https:\/\/doi.org\/10.1038\/ng.2764.","journal-title":"Nat Genet"},{"issue":"5","key":"3858_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2023.100852","volume":"18","author":"L Jiang","year":"2023","unstructured":"Jiang L, Qi Y, Yang L, et al. Remodeling the tumor immune microenvironment via siRNA therapy for precision cancer treatment. Asian J Pharm Sci. 2023;18(5):100852. https:\/\/doi.org\/10.1016\/j.ajps.2023.100852.","journal-title":"Asian J Pharm Sci"},{"issue":"13","key":"3858_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309388","volume":"11","author":"F Hu","year":"2024","unstructured":"Hu F, Huang J, Bing T, et al. Stimulus-responsive copper complex nanoparticles induce cuproptosis for augmented cancer immunotherapy. Adv Sci. 2024;11(13):2309388. https:\/\/doi.org\/10.1002\/advs.202309388.","journal-title":"Adv Sci"},{"issue":"1","key":"3858_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02828-3","volume":"22","author":"K Li","year":"2024","unstructured":"Li K, Wu L, Wang H, et al. Apoptosis and cuproptosis co-activated copper-based metal-organic frameworks for cancer therapy. J Nanobiotechnology. 2024;22(1):546. https:\/\/doi.org\/10.1186\/s12951-024-02828-3.","journal-title":"J Nanobiotechnology"},{"key":"3858_CR40","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jconrel.2024.05.045","volume":"371","author":"N Zhang","year":"2024","unstructured":"Zhang N, Ping W, Rao K, et al. Biomimetic copper-doped polypyrrole nanoparticles induce glutamine metabolism inhibition to enhance breast cancer cuproptosis and immunotherapy. J Control Release. 2024;371:204\u201315. https:\/\/doi.org\/10.1016\/j.jconrel.2024.05.045.","journal-title":"J Control Release"},{"issue":"12","key":"3858_CR41","doi-asserted-by":"publisher","first-page":"9031","DOI":"10.1021\/acsnano.3c12796","volume":"18","author":"G He","year":"2024","unstructured":"He G, Pan Y, Zeng F, et al. Microfluidic synthesis of CuH nanoparticles for antitumor therapy through hydrogen-enhanced apoptosis and cuproptosis. ACS Nano. 2024;18(12):9031\u201342. https:\/\/doi.org\/10.1021\/acsnano.3c12796.","journal-title":"ACS Nano"},{"issue":"13","key":"3858_CR42","doi-asserted-by":"publisher","first-page":"6282","DOI":"10.1039\/d5cs00083a","volume":"54","author":"L Mao","year":"2025","unstructured":"Mao L, Lu J, Wen X, et al. Cuproptosis: mechanisms and nanotherapeutic strategies in cancer and beyond. Chem Soc Rev. 2025;54(13):6282\u2013334. https:\/\/doi.org\/10.1039\/d5cs00083a.","journal-title":"Chem Soc Rev"},{"issue":"12","key":"3858_CR43","doi-asserted-by":"publisher","first-page":"9100","DOI":"10.1021\/acsnano.3c13225","volume":"18","author":"J Bao","year":"2024","unstructured":"Bao J, Wang J, Chen S, et al. Coordination self-assembled AuTPyP-Cu metal-organic framework nanosheets with pH\/ultrasound dual-responsiveness for synergistically triggering cuproptosis-augmented chemotherapy. ACS Nano. 2024;18(12):9100\u201313. https:\/\/doi.org\/10.1021\/acsnano.3c13225.","journal-title":"ACS Nano"},{"key":"3858_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216904","volume":"591","author":"J Choi","year":"2024","unstructured":"Choi J, Shin JY, Kim TK, et al. Site-specific mutagenesis screening in KRAS mutant library to uncover resistance mechanisms to KRASG12D inhibitors. Cancer Lett. 2024;591:216904. https:\/\/doi.org\/10.1016\/j.canlet.2024.216904.","journal-title":"Cancer Lett"},{"issue":"13","key":"3858_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202310529","volume":"36","author":"Y Shi","year":"2024","unstructured":"Shi Y, Wu Z, Qi M, et al. Multiscale bioresponses of metal nanoclusters. Adv Mater. 2024;36(13):e2310529. https:\/\/doi.org\/10.1002\/adma.202310529.","journal-title":"Adv Mater"},{"issue":"23","key":"3858_CR46","doi-asserted-by":"publisher","first-page":"21644","DOI":"10.1021\/acsnano.5c04379","volume":"19","author":"N Yan","year":"2025","unstructured":"Yan N, Wang Y, Wong TY, et al. Differential mapping of intracellular metallic nanoparticles and ions and dynamic modeling prediction. ACS Nano. 2025;19(23):21644\u201359. https:\/\/doi.org\/10.1021\/acsnano.5c04379.","journal-title":"ACS Nano"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03858-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03858-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03858-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T17:41:41Z","timestamp":1764178901000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03858-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3858"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03858-1","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Ethics Committee for Animal Experiments at the Department of laboratory Animals, Central South University (CSU-2023-0294). The minimum number of animals was used, and every attempt was made to reduce the suffering of the animals. All human tumor tissues used in this experiment were approved by the Ethics Committee at the Medical Ethics Committee of Xiangya Hospital, Central South University (202005397).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No LLM (e.g., ChatGPT) was used in manuscript preparation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Large language model (LLM) declaration"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"746"}}